Driven by a passion for technology and innovation, I specialize in leading complex IT Program & Project Management initiatives within the life sciences, biotech, and manufacturing sectors. My expertise lies in Manufacturing Execution Systems (MES), process automation, GxP compliance, and cross-functional team leadership, ensuring seamless execution of enterprise-level solutions.
With a strategic mindset and a hands-on approach, I have successfully managed large-scale systems integrations, vendor negotiations, and process improvement initiatives, consistently driving operational excellence and efficiency. My ability to bridge the gap between business needs and technical solutions has enabled organizations to implement cutting-edge digital transformations while maintaining regulatory compliance.
Key Expertise:
✅ IT Program & Project Management – Agile | Waterfall | SDLC | Risk & Stakeholder Management
✅ Manufacturing Execution Systems (MES) – Siemens OpCenter | Werum PAS-X | IBM Maximo | LIMS
✅ GxP Compliance & Validation – SOP Adherence | System Testing | Process Automation
✅ Systems Integration & Process Optimization – ERP | QMS | PI Historian | Lean Six Sigma
✅ Leadership & Collaboration – Vendor Management | Executive Reporting | Team Development
Career Highlights:
🔹 Amgen: Led key GxP-compliant Werum PAS-X MES implementations, a high-impact project that laid the foundation for multiple global initiatives. Recognized for delivering solutions that streamlined manufacturing and scheduling.
🔹 Pfizer | Seattle Genetics: Managed projects supporting biologics manufacturing expansion, including BAS, MES, and CMMS system integration, ensuring enterprise-wide alignment.
🔹 Gilead | Kite Pharma: Spearheaded the deployment of Benchling cloud-based R&D platform, enabling scientists to accelerate drug development.
🔹 Demant | Oticon: Drove regulatory compliance projects and led business process re-engineering efforts for new product launches.
🔹 Vericel Corporation: Currently overseeing MES system architecture, maintenance, and continuous improvement for a cell therapy & device manufacturer.
I am always open to connecting with like-minded professionals, discussing emerging technologies, and exploring opportunities to drive digital transformation in regulated industries. Let’s connect!
Panel Discussion
Monday, March 17
06:45 pm - 07:30 pm
Live in Everett
Less Details
The use of new technologies (AI, High-throughput screening) in drug discovery has created an unprecedented backlog of drug candidates in parallel to the increasing importance and success of biologics. The pressure to bring medicines to the patient faster increases the need to accelerate R&D and make tech transfer to manufacturing more efficient. The pressure to bring these innovative medicines to patients more quickly has intensified the need to streamline research and development (R&D) processes and improve the efficiency of technology transfer to manufacturing. Companies must focus on enabling faster and more efficient scale-ups from the pre-clinical phase through clinical trials and into commercial manufacturing. How do we harness the technologies available today to speed up product commercialization through Tech Transfer into Manufacturing? Key areas for discussion will include the following: